References
- Vargemezis V, Pasadakis P, Thodis H, Coucudis P, Peihaberis P, Jafer H, et al. Vancomycin therapy for Gram-positive peritonitis in patients on CAPD. Advances in Peritoneal Dialysis 1989; 5: 128–9
- D'Agata EM. Antimicrobial-resistant, Gram-positive bacteria among patients undergoing chronic haemodialysis. Clin Infect Dis 2002; 35: 1212–8
- Fluit AC, Schmitz FJ, Verhoef J, Milatovic D. Daptomycin in vitro susceptibility in European Gram-positive clinical isolates. Int J Antimicrob Agents 2004; 24: 59–66
- LaPlante KL, Mermel LA. In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model. Nephrol Dial Transplant 2007; 22: 2239–46
- Wise R, Gee T, Andrews JM, Dvorchik B, Marshall G. Pharmacokinetics and inflammatory fluid penetration of intravenous daptomycin in volunteers. Antimicrobial Agents Chemotherapy 2002; 46: 31–3
- Dvorchik B, Arbeit RD, Chung J, Liu S, Knebel W, Kastrissios H. Population pharmacokinetics of daptomycin. Antimicrob Agents Chemother 2004; 48: 2799–807
- Burkhardt O, Joukhadar C, Traunmueller F, Hadem J, Welte T, Kielstein JT. Elimination of daptomycin in a patient with acute renal failure undergoing extended daily dialysis. Journal of Antimicrobial Chemotherapy 2008; 61: 224–5
- Twardowski ZJ, Nolph KD, Khanna R, Prowant BF, Ryan LP, Moore HL, Nielsen MP. Peritoneal equilibration test. Perit Dial Bull 1987; 7: 138–47
- Martens-Lobenhoffer J, Kielstein JT, Oye C, Bode-Böger SM. Validated high performance liquid chromatography-UV detection method for the determination of daptomycin in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2008. ( Epub ahead of print).
- Hermsen ED, Hovde LB, Hotchkiss JR, Rotschafer JC. Antimicrobial increased killing of staphylococci and streptococci by daptomycin compared with cefazolin and vancomycin in an in vitro peritoneal dialysate Model. Agents and Chemotherapy 2003; 47: 3764–7